Dexamethasone Sodium Phosphate

地塞米松磷酸钠

Report date: 2026/03/30 17:02:26

Base Information

Drug NameDexamethasone Sodium Phosphate
Drug Alias NameDexamethasone 21-(disodium phosphate)地塞米松21-磷酸钠HexadrolAacidexamOradexon +[10] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonists
TargetsGlucocorticoid receptor
Therapy Area/IndicationsPlaque psoriasisLeg InjuriesIschemia +[86] 
Global Approved IndicationsInflammationAnaphylaxis
Approved Indications in ChinaInflammationAnaphylaxis
Original Approved Country/TerritoryJapan
Original Approved Date1959/11/01
Country/TerritoryUnited StatesTaiwanItaly +[7] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesRosemont Pharmaceuticals LtdSandoz Pharmaceutical Co Ltd
Inactive CompaniesQuince Therapeutics SPAEryDel SpAThe University Of Arizona +[9] 
Active IndicationsInflammationAnaphylaxis
Inactive IndicationsPlaque psoriasisLeg InjuriesIschemia +[84] 

Other Information

ATC CodeA01AC02C05AA09D07AB19 +[11] 
Related LinksWikipediaDrugBankKEGG